The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Genentech; Genomic Health; Immunomedics; InBiomotion; Novartis; Pfizer; Puma Biotechnology; Radius Health; Sandoz
Randomized trial of text messaging (TM) to reduce early discontinuation of aromatase inhibitor (AI) therapy in women with breast cancer: SWOG S1105.
 
Dawn L. Hershman
Consulting or Advisory Role - AIM Specialty Health
 
Joseph M. Unger
No Relationships to Disclose
 
Hillyer Grace
No Relationships to Disclose
 
Anna Moseley
No Relationships to Disclose
 
Kathryn B Arnold
No Relationships to Disclose
 
Shaker R. Dakhil
No Relationships to Disclose
 
Benjamin Esparaz
No Relationships to Disclose
 
Ming C. Kuan
No Relationships to Disclose
 
Mark Graham
No Relationships to Disclose
 
Douglas M Lackowski
No Relationships to Disclose
 
William Jeffery Edenfield
Speakers' Bureau - Astellas Medivation; Novartis
 
Zoneddy Ruiz Dayao
Consulting or Advisory Role - Celltrion; Teva
 
Julie Gralow
No Relationships to Disclose
 
Scott Ramsey
Consulting or Advisory Role - AstraZeneca; Bayer Health; Bristol-Myers Squibb/Pfizer; Cascadian Therapeutics; Epigenomics; Genentech; Kite, a Gilead company; Merck
 
Alfred I. Neugut
Stock and Other Ownership Interests - Stemline Therapeutics
Consulting or Advisory Role - EHE International; Otsuka; Pfizer; Teva; United Biosource Corporation